Sterilisation Assembly with Passage Decontamination for Parallel Assays

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing molecular diagnostic assays face challenges in increasing throughput while minimizing cross-contamination between sample sets, which limits the number of samples that can be tested due to the need for single-sample processing in controlled environments.

Innovation Solution

A sterilization assembly with a passage and decontaminator that restricts fluid communication across an enclosure, allowing samples to be processed on either side without cross-contamination, using a decontaminator to sterilize contamination passing through the passage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If samples are processed in separate controlled environments to avoid cross-contamination, then contamination risk is reduced, but sample throughput is limited

Engineering Contradiction:
Improvecontamination riskVSAvoidsample throughput
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The system divides the processing environment into separate zones (clean zone and contaminated zone) with controlled access between them. The enclosure with passage creates distinct segments that allow independent processing of multiple sample sets simultaneously while maintaining contamination barriers through defined fluid communication paths.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The passage acts as an intermediary element that controls fluid communication between zones. By restricting fluid communication to pass through the passage, the system enables controlled interaction between clean and contaminated zones, allowing throughput improvement while maintaining contamination prevention.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If multiple sample sets are processed simultaneously to increase throughput, then productivity is improved, but cross-contamination between sample sets increases

Engineering Contradiction:
Improvesample throughputVSAvoidcross-contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The enclosure creates segmented processing zones that allow multiple sample sets to be processed simultaneously in spatial separation. Each zone can handle different sample sets independently, enabling parallel processing while preventing cross-contamination through the enclosure barrier.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The passage serves as a controlled intermediary that mediates fluid communication between zones. By requiring all fluid communication to pass through this controlled interface, the system enables multiple simultaneous sample sets to be processed while maintaining strict contamination barriers.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If a barrier is introduced to restrict fluid communication and prevent contamination, then contamination control is improved, but device complexity increases

Engineering Contradiction:
Improvecontamination controlVSAvoidenclosure structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The barrier is implemented as a segmented enclosure structure that divides the system into distinct zones. This segmentation approach provides effective contamination control while keeping the structure manageable through modular zone definitions rather than a completely sealed complex system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The passage acts as a simplified intermediary that reduces overall system complexity. By concentrating fluid communication control into a single defined passage rather than multiple complex barriers, the system achieves effective contamination control with reduced structural complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12440589B2Sterilisation assembly
Publication Date: 2025.10.14 RANDOX LAB LTD
  • US12440589B2 patent drawing
  • US12440589B2 patent drawing
  • US12440589B2 patent drawing

AI summary

There is provided a sterilisation assembly for a molecular diagnostic assay analyse. The assembly comprising: an enclosure having a passage therethrough, the passage being arranged in use to allow an assay sample set to pass through the enclosure, the enclosure defining a barrier adapted in use to restrict fluid communication across the enclosure to communication through the passage; and a decontaminator located within the passage, the decontaminator is arranged in use to sterilise contamination in the passage.